MAJOR POPULATION DIFFERENCES IN T-CELL RESPONSE TO A MALARIA SPOROZOITE VACCINE CANDIDATE

被引:53
作者
ZEVERING, Y
HOUGHTEN, RA
FRAZER, IH
GOOD, MF
机构
[1] QUEENSLAND INST MED RES,TROP HLTH PROGRAM,BRAMSTON TERRACE,HERSTON,QLD 4006,AUSTRALIA
[2] UNIV QUEENSLAND,DEPT ZOOL,ST LUCIA,QLD 4067,AUSTRALIA
[3] TORREY PINES INST MOLEC STUDIES,SAN DIEGO,CA 92121
[4] UNIV QUEENSLAND,PRINCESS ALEXANDRA HOSP,DEPT MED,WOOLOONGABBA 4102,AUSTRALIA
基金
英国医学研究理事会;
关键词
Antibody-based vaccine; HLA differences; Malaria sporozoite; T cell response;
D O I
10.1093/intimm/2.10.945
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Using a complete series of overlapping peptides, we have identified the T cell epitopes of a malaria vaccine candidate, the circumsporozoite (CS) protein, that are recognized by sporozoiteexposed residents of a non-endemic country. Thls protein and subunb from tt are belng considered as malarla sporozoite vaccine candidates, as CS-specific antibodies and cytotoxic T lymphocytes have been shown to have a role in protection. The rationale for deveioplng an antibody-based vaccine is that in Plasmodium falclpmmthe lmmunodominant B cell epttope of the protein, (Asn-AieAsn-Ala-Asn-Pro)n, [(NANP)n], is invariant. However, the Ideal vaccine must contain CS protein-derived T cell antigenlc epttopes to allow natural boosting of the antibody response following sporozoite exposure. Here, we show that major differences occur between the CS spectific T cell responses of non-endemic Caucasians and an endemic African population. HLA differencaa between the populations are, in part, responsible. Subunit malaria vacclnes for one population may be ineffective In a different population. © Oxford University Press.
引用
收藏
页码:945 / 955
页数:11
相关论文
共 42 条
[1]   IMMUNOGENETICS AND MALARIA - MALARIA AND THE MAJOR HISTOCOMPATIBILITY COMPLEX [J].
ARNOT, D .
PARASITOLOGY TODAY, 1989, 5 (05) :138-142
[2]  
BALLOU WR, 1987, LANCET, V1, P1277
[3]  
Baur M.P., 1980, HISTOCOMPATIBILITY T, P955
[4]   PROTEIN ANTIGENIC STRUCTURES RECOGNIZED BY T-CELLS - POTENTIAL APPLICATIONS TO VACCINE DESIGN [J].
BERZOFSKY, JA ;
CEASE, KB ;
CORNETTE, JL ;
SPOUGE, JL ;
MARGALIT, H ;
BERKOWER, IJ ;
GOOD, MF ;
MILLER, LH ;
DELISI, C .
IMMUNOLOGICAL REVIEWS, 1987, 98 :9-52
[5]  
BRAKE DA, 1988, J IMMUNOL, V140, P1989
[6]   THE CIRCUMSPOROZOITE PROTEIN GENE FROM NF54, A PLASMODIUM-FALCIPARUM ISOLATE USED IN MALARIA VACCINE TRIALS [J].
CASPERS, P ;
GENTZ, R ;
MATILE, H ;
PINK, JR ;
SINIGAGLIA, F .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1989, 35 (02) :185-190
[7]  
CHIZZOLINI C, 1986, J IMMUNOL, V137, P1022
[8]   A CIRCUMSPOROZOITE-LIKE PROTEIN IS PRESENT IN MICRONEMES OF MATURE BLOOD STAGES OF MALARIA PARASITES [J].
COCHRANE, AH ;
UNI, SH ;
MARACIC, M ;
DIGIOVANNI, L ;
AIKAWA, M ;
NUSSENZWEIG, RS .
EXPERIMENTAL PARASITOLOGY, 1989, 69 (04) :351-356
[9]   STRUCTURE OF THE GENE ENCODING THE IMMUNODOMINANT SURFACE-ANTIGEN ON THE SPOROZOITE OF THE HUMAN MALARIA PARASITE PLASMODIUM-FALCIPARUM [J].
DAME, JB ;
WILLIAMS, JL ;
MCCUTCHAN, TF ;
WEBER, JL ;
WIRTZ, RA ;
HOCKMEYER, WT ;
MALOY, WL ;
HAYNES, JD ;
SCHNEIDER, I ;
ROBERTS, D ;
SANDERS, GS ;
REDDY, EP ;
DIGGS, CL ;
MILLER, LH .
SCIENCE, 1984, 225 (4662) :593-599
[10]  
DEGROOT AS, 1989, J IMMUNOL, V142, P4000